# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193805-24-001496
Filing Date
2024-12-18
Accepted
2024-12-18 16:36:12
Documents
17
Period of Report
2024-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | e664091_8k-immunic.htm iXBRL | 8-K | 24875
2 |  | e664091_ex10-1.htm | EX-10.1 | 99123
3 |  | e664091_ex10-2.pdf | 8-K | 273248
7 | GRAPHIC | image1.jpg | GRAPHIC | 6073
8 | GRAPHIC | image2.jpg | GRAPHIC | 4419
| Complete submission text file | 0001193805-24-001496.txt |  | 1079687

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | imux-20241213.xsd | EX-101.SCH | 3003
5 | XBRL LABEL FILE | imux-20241213_lab.xml | EX-101.LAB | 34240
6 | XBRL PRESENTATION FILE | imux-20241213_pre.xml | EX-101.PRE | 22351
19 | EXTRACTED XBRL INSTANCE DOCUMENT | e664091_8k-immunic_htm.xml | XML | 3779

Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 241559784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)